Sabby Management, LLC Amicus Therapeutics, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $1.3 Million - $2.08 Million	-155,044 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $1.35 Million - $1.93 Million	116,700 Added 304.35%	155,044 $1.87 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $348,811 - $454,012	-26,566 Reduced 40.93%	38,344 $599,000
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $893,161 - $1.11 Million	64,910 New	64,910 $976,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.